Pharma and Biotech
| Total Voting Rights | 28-Nov-2025 | 15:22 | RNS |
| Update re. US FDA ODD Application | 12-Nov-2025 | 07:01 | RNS |
| Results of Underwritten Open Offer | 12-Nov-2025 | 07:00 | RNS |
| Underwritten Open Offer | 28-Oct-2025 | 07:00 | RNS |
| Change of Auditor | 10-Oct-2025 | 07:00 | RNS |
| US FDA ODD Application Submitted for NXP002 | 11-Aug-2025 | 07:00 | RNS |
| Total Voting Rights | 30-May-2025 | 14:24 | RNS |
| Confirmation of European ODD for NXP002 | 29-May-2025 | 07:00 | RNS |
| Publication of a Prospectus | 23-May-2025 | 13:08 | RNS |
| £210,000 Placing | 22-May-2025 | 07:00 | RNS |
| Half-year Report | 02-May-2025 | 07:00 | RNS |
| Confirmation of European Orphan Drug Designation | 30-Apr-2025 | 07:00 | RNS |
| Change of Registered Office and Company Secretary | 29-Apr-2025 | 07:00 | RNS |
| Exercise of Warrants | 14-Apr-2025 | 07:00 | RNS |
| NXP002 Update | 09-Apr-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 0.26p |
| Change Today | 0.010p |
| % Change | 4.08 % |
| 52 Week High | 0.49 |
| 52 Week Low | 0.047 |
| Volume | 17,370,732 |
| Shares Issued | 2,109.75m |
| Market Cap | £5.38m |
| RiskGrade | 322 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:23 | 1 @ 0.27p |
| 16:21 | 1 @ 0.27p |
| 16:21 | 1 @ 0.27p |
| 16:16 | 1 @ 0.27p |
| 16:12 | 100 @ 0.27p |
You are here: research